# Proclear 1-D Multifocal Nondispensing Study

> **NCT01526902** · NA · COMPLETED · sponsor: **CooperVision, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DEVICE:** omafilcon A / PC 1-D MF
- **DEVICE:** lotrafilcon B / Air Optix MF

## Key facts

- **NCT ID:** NCT01526902
- **Lead sponsor:** CooperVision, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526902, "Proclear 1-D Multifocal Nondispensing Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01526902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
